Aquila Diagnostics is pleased to announce that has it been selected to present at the third annual Venture Summit West in Mountain View California on February 28-March 1.
The Alberta Diabetes Institute at the University of Alberta is pleased to announce a collaboration with Janssen Pharmaceuticals and its parent company Johnson & Johnson to advance early-stage technologies related to Type I and Type II diabetes.
Friday, February 10, 2017
Three organizations partner to establish $1.2M Alberta Transplant Innovation Fund. Through collaboration of researchers, clinicians, industry leaders, government and philanthropy, Funding research to improve care of transplant patients.